Given that, our results demonstrated that S100A4 might be involved in the pathomechanism of CRSwNP and contribute to the development of eosinophilic inflammation, and it might serve as a novel circulating biomarker to evaluate the severity of disease and distinguish endotypes in CRSwNP patients. Here, S100A4 is linked to chronic rhinosinusitis with nasal polyps.